CHPA announces RSQ conference speaker lineup

On the heels of its 2021 Regulatory, Scientific and Quality Conference, which will be held virtually from Sept. 9 to 10, the Consumer Health Products Association is sharing its speaker lineup.

Speakers include Janet Woodcock, the acting commissioner of the Food and Drug Administration; Cara Welch, the acting director of dietary supplement programs, CFSAN, FDA; and Jonette R. Foy, deputy office director, office of policy, CDRH, FDA.

In addition, attendees will be able to participate in breakout sessions with more than 30 speakers who will share their thoughts on the latest in regulatory, scientific and product quality in consumer health care.

[Related Content: CHPA names Ivan D. Combe Lifetime Achievement Award recipient]

Agenda highlights include an FDA/USP Leadership Panel discussion, Consumerization of Health Care, CBD — Regulatory, Legislative and Scientific Insights and Considerations for the Future of Rx-to-OTC Switches. The full lineup includes: 

• FDA/USP Leadership Panel Discussion;
• The Consumerization of Health Care;
• DSHEA 2.0;
• CBD – Regulatory, Legislative, and Scientific Insights;
• Considerations for the Future of Rx-to-OTC Switchesl
• Innovation Opportunities in Consumer Self-Care; and
• Impurities.

The company also said that there will be more than 15 on-demand sessions, including:

Dietary Supplement Sessions:

• Probiotics in 2021 - Science, Regulation and Marketplace;
• Safety Standards for Dietary Ingredients; and 
• Dietary Supplements Retailer Quality Programs.

Quality Sessions:

• Advancing Product Quality;
• Improving Environmental Sustainability in Our Business;
• Remote Quality Evaluations; and 
• Nitrosamines.

Regulatory Sessions:

• Maximizing Your FDA Project Manager/Sponsor Interactions;
• “Can We Say That?”...Lessons in Advertising During COVID-19; and 
• The "Why" & "How" Behind Selecting an OTC Drug Product Name.

A full list of speakers is available at the CHPA website.